Transcranial magnetic stimulation (TMS) is primarily used as an alternative or add-on depression treatment and for addressing behavioural- and addiction-based disorders.
Major Depressive Disorder (MDD) is a leading cause of global disability, and pharmacological intervention remains a cornerstone of its management. First-line agents typically comprise selective ...